Synteny

Private

LondonHealthcare & Life Scienceshttps://synteny.ai/

Last Round

Grant

Mar 1, 2024

Total Funding Raised

$3.17M

Company Overview

Synteny is a biotechnology company that develops an AI-driven platform for decoding molecular recognition to design precision TCR bispecific therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

drug discoveryprotein therapeuticsT-cell receptorTCRgenerative AIlab-in-the-loopAI drug discoveryprecision medicinesynthetic biologyprotein designbiotech platformin silico drug designcomputational biologybispecific antibodiesfoundational AIAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synteny Comps

Public and private peers based on sector, stage, and business model.

Synteny comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Synteny Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 1, 2024
Series A	Oct 1, 2023

View all Funding Rounds

Synteny Investors

Notable investors and investment history

Synteny investors
Investor	Rounds
Obvious Ventures	Series A
Amplifyher Ventures	Series A
Innovate UK	Grant
Black Opal Ventures	Series A
In-Q-Tel	Series A
Springboard Health Angels	Series A
MMC Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 5, 2024
Grew 25% QoQ from 12 to 15 employees.

View all signals

Synteny Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Synteny Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synteny's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range20

Year Founded2021

Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.